[bsa_pro_ad_space id=2]
ADVERTISEMENT
[bsa_pro_ad_space id=2]
ADVERTISEMENT
New York lawmakers are officially considering the “Medical Psilocybin Act,” legislation that would create legal access to psilocybin therapy for conditions like PTSD, treatment-resistant depression, substance use disorders, end-of-life distress, and cluster headaches.
With only days left in New York’s legislative session before June 4, this is a really important moment for visibility and public support as advocates work to move the bill through both chambers.
The biggest priority right now is getting as many New Yorkers as possible to speak up to their state assembly members and senators in support of the bill, and to spread awareness across platforms while momentum is building.